Search Results - "Fass, R"

Refine Results
  1. 1

    Management of heartburn not responding to proton pump inhibitors by Fass, R, Sifrim, D

    Published in Gut (01-02-2009)
    “…Patients with gastro-oesophageal reflux disease (GORD) who are not responding to proton pump inhibitors (PPIs) given once daily are very common. Various…”
    Get more information
    Journal Article
  2. 2

    Systematic review: proton‐pump inhibitor failure in gastro‐oesophageal reflux disease – where next? by FASS, R., SHAPIRO, M., DEKEL, R., SEWELL, J.

    Published in Alimentary pharmacology & therapeutics (15-07-2005)
    “…Summary Proton‐pump inhibitor failure has become a common clinical dilemma in gastrointestinal clinics and has been increasingly encountered at the primary…”
    Get full text
    Journal Article
  3. 3

    Clinical trial: lubiprostone in patients with constipation‐associated irritable bowel syndrome – results of two randomized, placebo‐controlled studies by DROSSMAN, D. A., CHEY, W. D., JOHANSON, J. F., FASS, R., SCOTT, C., PANAS, R., UENO, R.

    Published in Alimentary pharmacology & therapeutics (01-02-2009)
    “…Summary Background  Effective treatments for irritable bowel syndrome with constipation (IBS‐C) are lacking. Aim  To assess the efficacy and safety of…”
    Get full text
    Journal Article
  4. 4

    The lower esophageal sphincter by Hershcovici, T., Mashimo, H., Fass, R.

    Published in Neurogastroenterology and motility (01-09-2011)
    “…The lower esophageal sphincters (LES) together with the crural diaphragm are the major antireflux barriers protecting the esophagus from reflux of gastric…”
    Get full text
    Journal Article
  5. 5

    The relationship between eosinophilic esophagitis and esophageal cancer by Syed, A., Maradey-Romero, C., Fass, R.

    Published in Diseases of the esophagus (01-07-2017)
    “…SUMMARY Eosinophilic esophagitis (EoE) is a disorder characterized by long-term chronic eosinophilic inflammation, which may predispose patients for malignant…”
    Get full text
    Journal Article
  6. 6

    Utilisation of surgical fundoplication for patients with gastro‐oesophageal reflux disease in the USA has declined rapidly between 2009 and 2013 by Khan, F., Maradey‐Romero, C., Ganocy, S., Frazier, R., Fass, R.

    Published in Alimentary pharmacology & therapeutics (01-06-2016)
    “…Summary Background Surgical fundoplication has been considered to be one of the leading therapeutic modalities for gastro‐oesophageal reflux disease (GERD)…”
    Get full text
    Journal Article
  7. 7

    Review article: the current treatment of non‐cardiac chest pain by George, N., Abdallah, J., Maradey‐Romero, C., Gerson, L., Fass, R.

    Published in Alimentary pharmacology & therapeutics (01-01-2016)
    “…Summary Background Non‐cardiac chest pain is one of the most common functional gastrointestinal disorders. By recognising that gastro‐oesophageal reflux…”
    Get full text
    Journal Article
  8. 8

    Functional heartburn: the stimulus, the pain, and the brain by Fass, R, Tougas, G

    Published in Gut (01-12-2002)
    “…Functional heartburn is a common disorder and appears to be composed of several distinct subgroups. Identifying the different subgroups based on clinical…”
    Get full text
    Journal Article Book Review
  9. 9
  10. 10

    The 2011–2014 prevalence of eosinophilic oesophagitis in the elderly amongst 10 million patients in the United States by Maradey‐Romero, C., Prakash, R., Lewis, S., Perzynski, A., Fass, R.

    Published in Alimentary pharmacology & therapeutics (01-05-2015)
    “…Summary Background Eosinophilic oesophagitis (EoE) is primarily diagnosed by clinicians. There are less than a handful of epidemiological studies in EoE that…”
    Get full text
    Journal Article
  11. 11

    The role of pain modulators in esophageal disorders – no pain no gain by Dickman, R., Maradey‐Romero, C., Fass, R.

    Published in Neurogastroenterology and motility (01-05-2014)
    “…Pain modulators have been primarily used for the management of functional esophageal disorders. Recently, these drugs have also been used for the management of…”
    Get full text
    Journal Article
  12. 12

    Systematic review: the treatment of noncardiac chest pain by Hershcovici, T., Achem, S. R., Jha, L. K., Fass, R.

    Published in Alimentary pharmacology & therapeutics (01-01-2012)
    “…Aliment Pharmacol Ther 2012; 35: 5–14 Summary Background  Treatment of noncardiac chest pain (NCCP) remains a challenge. This is in part due to the…”
    Get full text
    Journal Article
  13. 13

    Step‐by‐step management of refractory gastresophageal reflux disease by Hershcovici, T., Fass, R.

    Published in Diseases of the esophagus (01-01-2013)
    “…SUMMARY Up to a third of the patients who receive proton pump inhibitor (PPI) once daily will demonstrate lack or partial response to treatment. There are…”
    Get full text
    Journal Article
  14. 14

    Systematic review: the effects of carbonated beverages on gastro‐oesophageal reflux disease by JOHNSON, T., GERSON, L., HERSHCOVICI, T., STAVE, C., FASS, R.

    Published in Alimentary pharmacology & therapeutics (01-03-2010)
    “…Aliment Pharmacol Ther 31, 607–614 Summary Background  Carbonated beverages have unique properties that may potentially exacerbate gastro‐oesophageal reflux…”
    Get full text
    Journal Article
  15. 15

    High resolution vs conventional esophageal manometry in the assessment of esophageal motor disorders in patients with non‐cardiac chest pain by Akinsiku, O., Yamasaki, T., Brunner, S., Ganocy, S., Fass, R.

    Published in Neurogastroenterology and motility (01-06-2018)
    “…Background High‐resolution esophageal manometry (HREM) has become a leading tool in the assessment of esophageal motor disorders, replacing conventional…”
    Get full text
    Journal Article
  16. 16

    Non‐erosive reflux disease (NERD) — acid reflux and symptom patterns by Martinez, S. D., Malagon, I. B., Garewal, H. S., Cui, H., Fass, R.

    Published in Alimentary pharmacology & therapeutics (01-02-2003)
    “…Summary Background: Recent reports suggest that patients with non‐erosive reflux disease (NERD) treated with anti‐reflux medications show lower symptom…”
    Get full text
    Journal Article
  17. 17

    Systematic review: the relationship between interstitial lung diseases and gastro‐oesophageal reflux disease by Hershcovici, T., Jha, L. K., Johnson, T., Gerson, L., Stave, C., Malo, J., Knox, K. S., Quan, S., Fass, R.

    Published in Alimentary pharmacology & therapeutics (01-12-2011)
    “…Aliment Pharmacol Ther 2011; 34: 1295–1305 Summary Background  A potential relationship has been suggested between gastro‐oesophageal reflux disease (GERD) and…”
    Get full text
    Journal Article
  18. 18

    Non‐cardiac chest pain: an update by Fass, R., Dickman, R.

    Published in Neurogastroenterology and motility (01-06-2006)
    “…Non‐cardiac chest pain (NCCP) is very common, affecting up to a quarter of the USA adult population. Recent studies have shown that the disorder has a profound…”
    Get full text
    Journal Article
  19. 19

    Systematic review with meta‐analysis: selective serotonin reuptake inhibitors for noncardiac chest pain by Atluri, D. K., Chandar, A. K., Fass, R., Falck‐Ytter, Y.

    Published in Alimentary pharmacology & therapeutics (01-01-2015)
    “…Summary Background Selective serotonin reuptake inhibitors (SSRIs) are used to treat noncardiac chest pain (NCCP) symptoms, however, data regarding their…”
    Get full text
    Journal Article
  20. 20